Selvita S.A. has completed its strategic acquisition of PozLab, a CDMO offering drug product development services and small pilot plant capabilities, including analytical, formulation, and process development competencies, followed by microbiological testing.    PozLab holds a GMP license for the manufacture of medical and investigational products. The company currently employs over 80 subject matter experts and is located in state-of-the-art R&D facilities in Poznan, Poland, which offer a...